Table of Contents
Devoted Health is seeking a new funding round at a $25 billion valuation as investor interest in AI-driven Medicare Advantage companies grows, as first reported by Business Insider, marking a striking Devoted Health $25 billion valuation milestone for the startup.
How This Devoted Health $25 Billion Valuation Compares to Its Prior Round
Devoted Health is in talks to raise a new funding round at a $25 billion valuation, up from $16 billion earlier this year. According to people familiar with the matter, the Waltham, Massachusetts-based startup is discussing this new capital raise just months after announcing its previous financing, indicating a sharp increase in investor expectations for the company as it expands in Medicare Advantage.
A Company Built by Healthcare and Tech Veterans
Devoted Health was founded in 2017 by brothers Ed and Todd Park, both former healthcare executives. Ed Park previously served as chief operating officer at athenahealth, while Todd Park was the U.S. chief technology officer under President Obama, giving the company’s leadership a combined background spanning both healthcare operations and federal technology policy.
The Membership Growth Behind This Devoted Health $25 Billion Valuation
Membership reached 466,000 as of January 2026, marking a 121% year-over-year increase as the company scales in Medicare Advantage. This growth rate substantially outpaces the broader Medicare Advantage market, where several major national insurers have instead been scaling back membership and exiting plans amid cost pressures.
Why This Growth Stands Out Industrywide
Devoted’s rapid expansion arrives at a moment when established national insurers like Humana, Molina, and Providence have all announced Medicare Advantage pullbacks or exits for 2027, making Devoted’s 121% year-over-year growth a notable outlier within a broader industry trend of retrenchment.
The Orinoco AI Platform Driving Devoted Health $25 Billion Valuation Interest
Investor enthusiasm is driven by Devoted Health’s proprietary AI platform Orinoco and rapid growth in government-funded Medicare Advantage revenue. The company combines health insurance and medical care for older adults enrolled in Medicare Advantage, and uses its proprietary AI tool to help coordinate care for members, positioning Devoted as both an insurer and a healthcare provider simultaneously.
Why This Integrated Model Matters for Valuation
By generating most of its revenue through government-funded Medicare Advantage premiums while also directly delivering care through its own provider arm, Devoted Health’s dual insurer-provider structure gives investors exposure to both sides of the Medicare Advantage value chain, a model that may explain part of the outsized valuation growth relative to pure-play insurers.
Devoted Health’s Broader Funding History Behind This $25 Billion Valuation Talk
The company’s most recent confirmed funding round closed in January 2026, a $317 million raise led by Centricus, part of a broader fundraising history that has brought Devoted’s total capital raised to more than $2.6 billion across nine rounds from 46 investors since its 2017 founding.
A Company Spokesperson’s Response
A company spokesperson said Devoted Health does not comment on its capital raising activity, a standard non-disclosure response common among private companies navigating active fundraising discussions before terms are finalized.
What This Devoted Health $25 Billion Valuation Talk Means Going Forward
With this potential valuation representing more than a 50% increase from the company’s $16 billion mark earlier this year, Devoted Health’s fundraising trajectory suggests investors remain highly confident in AI-driven Medicare Advantage models even as the broader sector faces cost pressures and consolidation. Given the company’s 121% year-over-year membership growth against a backdrop of competitor pullbacks, Devoted’s continued expansion may offer a case study in how a technology-forward, vertically integrated approach can outperform traditional Medicare Advantage insurers during a period of broader industry retrenchment.
What to Watch Going Forward
As this funding round moves from discussion toward finalization, industry observers will likely watch whether Devoted Health closes at or near the reported $25 billion figure, and how the company’s Orinoco AI platform continues to differentiate its care coordination model from competitors. Given the sharp contrast between Devoted’s growth trajectory and the pullbacks seen at major national insurers, this Devoted Health $25 billion valuation talk may serve as a bellwether for whether investors increasingly favor AI-native, vertically integrated Medicare Advantage startups over legacy insurance models as the sector continues evolving.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
